BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17679486)

  • 1. Medical treatment of uveal melanoma.
    Queirolo P; Acquati M
    Tumori; 2007; 93(3):suppl 27-30. PubMed ID: 17679486
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of malignant melanoma at the stage of distant metastasis].
    Garbe C; Eigentler TK
    Hautarzt; 2004 Feb; 55(2):195-213. PubMed ID: 15043023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment and other combination regimens.
    Bajetta E; Del Vecchio M; Bajetta R; Canova S
    Tumori; 2007; 93(3):suppl 22-6. PubMed ID: 17679485
    [No Abstract]   [Full Text] [Related]  

  • 4. Treosulfan and gemcitabine.
    Cree IA; Neale MH; Reinhold U; Kurbacher CM
    J Cancer Res Clin Oncol; 2005 May; 131(5):329-30; author reply 331. PubMed ID: 15700153
    [No Abstract]   [Full Text] [Related]  

  • 5. Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study.
    Pföhler C; Cree IA; Ugurel S; Kuwert C; Haass N; Neuber K; Hengge U; Corrie PG; Zutt M; Tilgen W; Reinhold U
    Anticancer Drugs; 2003 Jun; 14(5):337-40. PubMed ID: 12782938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
    Niederkorn A; Wackernagel W; Artl M; Schwantzer G; Aigner B; Richtig E
    Acta Ophthalmol; 2014 Dec; 92(8):e696-7. PubMed ID: 24774993
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of metastatic malignant uveal melanoma].
    Jäckel A; Bock M; Deichmann M; Waldmann V; Näher H
    Hautarzt; 2001 Feb; 52(2):98-103. PubMed ID: 11244899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours.
    Keilholz U; Schuster R; Schmittel A; Bechrakis N; Siehl J; Foerster MH; Thiel E
    Eur J Cancer; 2004 Sep; 40(14):2047-52. PubMed ID: 15341977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.
    Schmittel A; Scheulen ME; Bechrakis NE; Strumberg D; Baumgart J; Bornfeld N; Foerster MH; Thiel E; Keilholz U
    Melanoma Res; 2005 Jun; 15(3):205-7. PubMed ID: 15917703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveal melanoma therapy on the horizon?
    Cancer Discov; 2014 Sep; 4(9):OF6. PubMed ID: 25185205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients.
    Corrie PG; Shaw J; Spanswick VJ; Sehmbi R; Jonson A; Mayer A; Bulusu R; Hartley JA; Cree IA
    Br J Cancer; 2005 Jun; 92(11):1997-2003. PubMed ID: 15886706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of bendamustine chemotherapy as second-line treatment in metastatic uveal melanoma.
    Schmidt-Hieber M; Schmittel A; Thiel E; Keilholz U
    Melanoma Res; 2004 Dec; 14(6):439-42. PubMed ID: 15577312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma.
    Terheyden P; Bröcker EB; Becker JC
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):395-9. PubMed ID: 15160290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
    Mian M; Farsad M; Pescosta N; Casini M; Cavattoni IM; Deola S; Cortelazzo S
    Ann Hematol; 2013 Jan; 92(1):121-3. PubMed ID: 22820997
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of melanoma].
    Dréno B; Wallon-Dumont G
    Presse Med; 2003 Jan; 32(1):39-43. PubMed ID: 12610396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients.
    Atzpodien J; Terfloth K; Fluck M; Reitz M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):685-8. PubMed ID: 18084763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma.
    Schmittel A; Schmidt-Hieber M; Martus P; Bechrakis NE; Schuster R; Siehl JM; Foerster MH; Thiel E; Keilholz U
    Ann Oncol; 2006 Dec; 17(12):1826-9. PubMed ID: 16971664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selumetinib shows promise in metastatic uveal melanoma.
    Cancer Discov; 2013 Jul; 3(7):OF8. PubMed ID: 23847383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.
    Schuster R; Lindner M; Wacker F; Krössin M; Bechrakis N; Foerster MH; Thiel E; Keilholz U; Schmittel A
    Melanoma Res; 2010 Jun; 20(3):191-6. PubMed ID: 20335820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201).
    Luke JJ; Olson DJ; Allred JB; Strand CA; Bao R; Zha Y; Carll T; Labadie BW; Bastos BR; Butler MO; Hogg D; Munster PN; Schwartz GK
    Clin Cancer Res; 2020 Feb; 26(4):804-811. PubMed ID: 31558480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.